All News

The virus has now reached all continents except Antarctica, with cases reported in 47 countries.

Depending on the amount consumed, intake of dairy milk can increase the risk of breast cancer by up to 80%, according to new research from Loma Linda University Health.

Top News of the Week from Directions in Specialty Pharmacy.

The medication works by blocking CGRP receptors, treating a root cause of migraine.

As health care costs continue to rise in the United States, crowdfunding on websites such as GoFundMe is becoming increasingly common.

Researchers report promising activity with a novel drug that targets a key molecular driver of clear cell renal cell carcinoma in patients with metastatic disease.

Ancient Egyptians wrote some of the oldest pharmaceutical records, including prescriptions. How many centuries ago do some of the oldest records date back to?

As pharmacists, patients are inquiring about these kits already, and recommending such items can help prevent a lot of worry.

According to a new report from the Leonard D. Schaeffer Center for Health Policy and Economics, a $1 increase in drug rebates was associated with a $1.17 rise in list prices, hurting uninsured patients who pay list prices and insured patients who pay coinsurance and deductibles based on list prices.

In order to increase the effectiveness of adherence interventions, we need to take into account the fact that human beings are not always rational.

This is the first newly approved therapy for high risk locally advanced squamous cell carcinoma of LA-SCCHN in 25 years.

Bempedoic acid and ezetimibe combined is the first non-statin, LDL-C lowering combination medicine ever approved, according to Esperion.

Top news from across the health care landscape.

Two recently approved leukemia drugs could be enlisted against treatment-resistant lung cancer.

Officials from the FDA have approved a supplemental New Drug Application (sNDA) for neratinib (NERLYNX, Puma Biotechnology) in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer that have received 2 or more prior anti-HER2-based regimens in the metastatic setting.

Four FDA-approved products that face no competition may increase health care spending by as much as $20.25 billion, according to a new analysis by Vizient Inc.1

In the matter of California State Board of Pharmacy vs Pacifica Pharmacy and Thang Tran, action was taken by the board against a pharmacist accused of poor oversight, and judgment over occurrences at a community pharmacy under his watch.

Research conducted by the National Institute of Minority Health and Health Disparities has found that less than 1 in 4 adolescent men who have sex with men (AMSM) ever get tested for HIV.

The report enables hospital and health systems to focus their medication safety efforts over the next 2 years on these best practices.

Retail giants such as Walmart, AT&T, and Best Buy are moving into the health care space by effectively transforming their best selling assets into health care tools.

Top news from across the health care landscape.

A recent patient survey conducted by Human Care Services uncovered a genuine significant desire from patients for help from drug manufacturers in managing their conditions and drug regimens.

Accidental medication ingestion can result in hospitalization and even death, posing a serious threat to young children.

The FDA and the White House also announced new initiatives to combat the novel coronavirus.

A study published in Neuron suggests that targeting astrocyte calcium signaling could decrease the behavioral effects of amphetamine.

As the Supreme Court prepares to hear oral arguments in Rutledge v. Pharmaceutical Care Management Association (PCMA), several states are moving forward with their own legislation to limit the influence of pharmacy benefit managers (PBMs) in managed care organizations.

Ongoing legislative efforts to remove religious exemptions from vaccinations have led to protests by vocal anti-vaccination advocates, who claim that the bills limit the right of parents to care for their children.

In recent years, drugmakers have been accused of pushing opioid prescriptions on physicians across the United States and allegedly downplaying the risks of addiction. Meanwhile, governments feel that distributors and pharmacies have turned a blind eye to suspicious orders and failed to meet government requirements on painkillers.

The product will be immediately launched with limited commercial qualities, and manufacturers expect that there will be a steady supply by the fourth quarter of 2020.

Top news from across the health care landscape.